SEC Form 4 · accession 0001144204-18-020524
BIOHITECH GLOBAL, INC. · BHTG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Apr 11, 2018
Accepted (ET)
Apr 13, 2018 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590383
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001F1,F2 | Apr 11, 2018 | C | 36,364 | $2.75 | A | 873,660 | I | Held by Conundrum Capital Partners, LLC |
| Common Stock, par value $0.0001F3,F2 | Apr 11, 2018 | C | 3,204 | $4.994 | A | 876,864 | I | Held by Conundrum Capital Partners, LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Promissory NoteF3 | $2.75 | Apr 11, 2018 | C | 1 | D | Apr 11, 2018 | Apr 11, 2018 | Common Stock | 36,364 | 0 | I |
Explanation of responses
- F136,364 shares at $2.75 per share represent the conversion at maturity of a convertible note initially entered into on February 10, 2016 (the "Note").
- F2Mr. VanOort holds voting and dispositive power over Conundrum Capital Partners, LLC.
- F33,204 shares at $4.994 per share represent the payment of interest at 8% on the Note.